MedTech

Innovation That Transforms Patient Care

MedTech companies develop critical technologies that directly impact patient outcomes across diverse healthcare applications. Proprietary technology, regulatory approvals, and proven clinical efficacy create significant barriers to entry. Consumer trends are also disrupting traditional medical device paradigms, with a new set of buyers and investors seeking clinically-validated technologies to assist health-focused consumers.

Our expert team knows how to position companies with established market demand, proven track records, and measurable improvements in patient care for growth investors and strategic acquirers. Whether a best-in-class therapeutic device or a white space market opportunity, acquirers and investors actively seek innovative solutions to drive better patient outcomes and shareholder value.

Featured Transactions

*Completed by a Mirus professional at a prior firm

Explore More Transactions

What Clients Are Saying

“When we founded our organization, it was with one simple goal in mind...to EMPOWER bystanders at the scene of a medical emergency to help save lives. Now that we are partnered with ZOLL we can do this on a large scale. Mirus helped make this happen and I am forever grateful for that. You were a pleasure to work with and were able to keep me focused and positive through the process.”

Jason Gotham, PresidentMobilize Rescue Systems

Meet Our MedTech Experts

Brendan Kiernan
Partner and Co-head of Business Services, Healthcare & Life Sciences
Brendan Kiernan Headshot | Mirus Capital Advisors
Patrick West
Partner & Co-head of Healthcare and Life Sciences
Patrick West Headshot | Mirus Capital Advisors
Thom Busby
Partner and Co-head of Healthcare & Life Sciences
Thom Busby Headshot | Mirus Capital Advisors
Nick Frame, PhD
Director
Nick Frame Headshot | Mirus Capital Advisors

Featured Report

Mirus Capital Advisors | Healthcare Sector | Medical Device Report | Q3 2025

Q3 2025 Medical Device Report

An in-depth look at the Q3 2025 Medical Device sector, where Mirus’ partners apply their expertise and experience to take a closer look at news, transactions, and state of the industry.

Download Report

News & Insights

December 8, 2025

Mirus Capital Advisors Recognized as “Investment Bank of the Year – Complex Transactions” at M&A Advisor Awards

Read More
September 16, 2025

Mirus Capital Advisors Expands Life Sciences & Healthcare Investment Banking Team with Strategic Additions of Thomas Busby and Nick Frame, PhD

Read More

Let’s Start a Conversation

Leverage our team’s expertise for your MedTech company.

Name(Required)